FIDELIO-DKD demonstrated a significant reduction in kidney failure and CV outcomes (HR 0.82 for the primary kidney composite), complemented by FIGARO-DKD and consolidated in the FIDELITY pooled analysis, which showed a 23% reduction in major kidney outcomes and a consistent effect across CKD stages
The monitoring protocol is well-established because the drug has been in clinical use for years
"Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function." European Journal of Clinical Nutrition
Delicious Flavors: Available in two refreshing flavors - Green Mango and Watermelon Twist, making your supplement intake enjoyable
These conditions and causes include emphysema, asthma, allergic disorders, drug toxicity, metabolic disorders, cancer, chemotherapy and human immunodeficiency virus-acquired immune deficiency syndrome, among others